Wolters Kluwer Announces Partnership with the FNCP to Improve Clinical Decision-Making in Spain

Wolters KluwerWolters Kluwer, a leading global provider of information for healthcare professionals and students, has announced a new partnership with the Federación Nacional de Clínicas Privadas (FNCP), an organization representing over 550 of the private healthcare institutions in Spain.

The collaboration reflects Wolters Kluwer's focus on fostering growth in the Spanish market and broadening adoption of UpToDate®, the clinical decision support resource used by more than 1 million doctors worldwide. The partnership supports a common mission of the FNCP and Wolters Kluwer to improve care in hospitals and clinics across the country.

Carlos Rus, managing director of FNCP, commented that it is essential to support "any option to improve patient care and promote excellence in healthcare. For the FNCP, it is very important to offer our members services like this, that can bring agility, information, knowledge, safety and quality, to both managers and health centers as well as patients themselves."

As the FNCP strategically focuses on ensuring a higher quality of care and better health outcomes, UpToDate helps member institutions realize these goals by equipping clinicians with access to the most current clinical recommendations to make the best decisions for patients. Working with the FNCP also complements access to UpToDate currently available at over 300 healthcare sites in the Sistema Nacional de Salud (SNS), Spain's national health system operated by Spain's Ministry of Health, Social Services and Equality.

"UpToDate provides clinicians throughout Spain with evidence-based recommendations to make better care decisions for their patients," says Denise Basow, MD, Vice President and General Manager, UpToDate at Wolters Kluwer, Clinical Solutions. "Our partnership with the FNCP forms an important part of our mission to improve the quality and effectiveness of healthcare throughout Spain."

About Wolters Kluwer
Wolters Kluwer is a global leader in professional information services. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance and healthcare rely on Wolters Kluwer's market leading information-enabled tools and software solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.

Wolters Kluwer reported 2014 annual revenues of €3.7 billion. The group serves customers in over 170 countries, and employs over 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on NYSE Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...